ABCL

#2371
AbCellera Biologics Inc. Common Shares
3.76 USD
+2.73%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
3.76
3.76
年范围
1.94
6.52
日变化
+2.73%
每月变动
+6.52%
6个月变化
-33.69%
年变化
+55.37%
前一天收盘价
3.66
开盘价
3.76
买价
卖价
最低价
3.76
High
3.76
交易量
45
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 1.14 B
  • Employee 562
  • Founded 2012
  • CEO Carl Hansen
  • Website www.abcellera.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00LLW2MF2
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-6.98
市销率
13.6

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

新闻